Recruiting Myasthenia Gravis Studies in Palo Alto
KYSA-6: A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy, in Patients With Generalized Myasthenia Gravis
A Study of the Anti-CD 19 Chimeric Antigen Receptor T Cell Therapy for Patients with Myasthenia Gravis...
A Study of Nipocalimab in Children Aged 2 to Less Than 18 Years With Generalized Myasthenia Gravis
The purpose of this study is to determine the effect of nipocalimab on total serum immunoglobulin G (IgG) in pediatric participants 2 to less than (\<) 18 years of age (globally) and 8 to \<18 years o...
About Myasthenia Gravis Clinical Trials in Palo Alto
Myasthenia gravis is a chronic autoimmune neuromuscular disease that causes weakness in the skeletal muscles responsible for breathing and movement. It occurs when communication between nerves and muscles is disrupted. Treatment includes medications that improve neuromuscular transmission and immunosuppressive therapies.
There are currently 2 myasthenia gravis clinical trials recruiting participants in Palo Alto, CALIFORNIA. These studies are seeking a combined 78 participants. Research is being sponsored by Kyverna Therapeutics, Janssen Research & Development, LLC. Clinical trial participation is free and participants receive study-related medical care at no cost.
Myasthenia Gravis Clinical Trials in Palo Alto — FAQ
Are there myasthenia gravis clinical trials in Palo Alto?
Yes, there are 2 myasthenia gravis clinical trials currently recruiting in Palo Alto, CALIFORNIA. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Palo Alto?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Palo Alto research site will contact you about next steps.
Are clinical trials in Palo Alto free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Palo Alto studies also compensate for your time and travel.
What myasthenia gravis treatments are being tested?
The 2 active trials in Palo Alto are testing new therapies including novel drugs, biologics, and treatment approaches for myasthenia gravis.
Data updated March 2, 2026 from ClinicalTrials.gov